MENS — Jyong Biotech Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Jyong Biotech, fiscal year end - December 31st, millions except per share.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | — | 12 M |
| Source: | PROSPECTUS | |
| Standards: | — | USG |
| Status: | fx Preliminary | Final |
| Net Income/Starting Line | — | -4.4 |
| Depreciation | ||
| Non-Cash Items | — | 0.554 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | — | 1.12 |
| Change in Prepaid Expenses | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Change in Other Liabilities | ||
| Cash from Operating Activities | — | -2.6 |
| Capital Expenditures | — | 0 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | — | 0.095 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Cash from Investing Activities | — | 0.095 |
| Financing Cash Flow Items | — | -0.445 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | — | 2.03 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | — | -0.532 |